Amplia Therapeutics Ltd. (INNMF)

[BC239]

Probably only weeks away until the Top Line data is released. That likely will tell the story of the results of the 2B. If it's positive as expected it should certainly pique the interest of the pharma companies who would like such a drug in their line up.
I sure hope that it shows it's been effective in 70+% of the 2B patients. That would be consistent with the results of the compassionate care users and would be a fantastic result.